跳至主要内容
临床试验/CTRI/2024/02/062340
CTRI/2024/02/062340尚未招募3 期

Molecular characterization of hypoxia inducing factor (HIF) and angiogenic cytokine and their correlations with neoadjuvant chemotherapy in addition with hyperbaric oxygen therapy in breast cancer patients. - NACT

Aiims New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All female patients of invasive breast carcinoma (Early or Locally advanced) planned for neoadjuvant chemotherapy

排除标准

  • 1. Pregnant women
  • 2. Lactating women
  • 3. Contraindication to HBOT -
  • a. middle ear infections
  • b. eustachian tube blockage
  • c. chronic obstructive pulmonary disease
  • d. emphysema
  • 4. Contraindication to systemic chemotherapy
  • 5. Poor performance score
  • 6. Significant co-morbidities
  • 7. Women refusing consent.
  • 8. >4 organs involved in metastasis not amenable to resection
  • 9. Recurrent breast cancer
  • 10. Inflammatory breast cancer

研究者

发起方
Aiims New Delhi

相似试验